Luke Wharton - TRIUMF | 人才画像

基本信息

浏览量：4

职业迁徙

个人简介

Luke Wharton currently works in the Life Sciences Division at TRIUMF, Vancouver, Canada. Luke does research in Radiopharmaceutical chemistry, Inorganic Chemistry, Organic Chemistry and Chemical Biology. His most recent publication is 'H4 picoopa ─ Robust Chelate for 225 Ac/ 111 In Theranostics'

研究兴趣

论文共 40 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Chelating [227th]th4+ for Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors

Luke Wharton, Scott W McNeil, Harrison Meeres, Diduo Zhang,Aidan Ingham,Helen Merkens,Maryam Osooly,Cristina Rodríguez-Rodríguez,François Bénard,Hua Yang

Bioconjugate chemistryno. 6 (2025): 1273-1287

引用0浏览0WOS引用

Novel Direct Alpha Spectroscopy Technique for ^225ac Radiopharmaceutical Detection in Cancer Cells

Mahsa Farasat, Behrad Saeedi,Luke Wharton, Sidney Shapiro, Chris Vinnick, Madison Daignault, Meghan Kostashuk, Nicholas Pranjatno, Myla Weiman,Corina Andreoiu, Hua Yang, Peter Kunz

arxiv（2025）

引用0浏览0引用

Novel Direct Alpha Spectroscopy Technique For225ac Radiopharmaceutical Detection in Cancer Cells

Mahsa Farasat, Behrad Saeedi Saghez,Luke Wharton, Sidney Shapiro, Chris Vinnick, Madison Daignault, Meghan Kostashuk, Nicholas Pranjatno, Myla Weiman, Corina Andreoiu,Hua Yang,Peter Kunz

Physics in medicine and biologyno. 11 (2025)

引用0浏览0WOS引用

Preclinical Evaluation of [225Ac]ac-Crown-tate – an Alpha-Emitting Radiopharmaceutical for Neuroendocrine Tumors